56 research outputs found
Early Career Support for Biomedical Exchange Students with an International Mentor-to-Mentor Concept - The Biomedical Education Program (BMEP)
In medicine, many international exchange opportunities exist, yet often only towards the end of the course of study. Opportunities for students to gain high-level international research experience early during the studies are rare. A good student-mentor relationship during a research stay abroad is a key factor for scientific success. The aims of this paper are to report on an international exchange and education program that has funded more than 700 students and has been carefully developed and advanced over more than 40 years, its mentor-to-mentor concept and potential success factors for building and maintain such programs. A summary of the history, the concept and the experiences of students is provided, along with a discussion of evaluation results and success factors. The Biomedical Education Program (BMEP) team has - within the last seven years of leadership by the authors - selected and funded 83 German students from different biomedical studies who went abroad for research projects. Preliminary evaluation results show a high degree of satisfaction with the program and its mentor-to-mentor concept, which we deem to be the key to success. Further factors include continued funding, determination, self-organization and assertiveness, an excellent alumni network and a meticulous selection process for both, students and hosts. Further, more detailed evaluation of survey results has to follow. Our results may support the build-up of similar exchange programs
study protocol for a randomized controlled trial
Background For the surgical treatment of recurrent primary spontaneous
pneumothoraces (rPSP) different operative therapies are applied to achieve
permanent freedom from recurrence. Methods/design This multicenter clinical
trial evaluates the long-term results of two commonly applied surgical
techniques for the treatment of rPSP. Based on the inclusion and exclusion
criteria, and after obtaining the patients’ informed consent, participants are
randomized into the two surgical treatment arms: pulmonary wedge resection
plus parietal pleurectomy (WRPP) or parietal pleurectomy alone (PP).
Consecutively, all study participants will be followed up for two years to
evaluate the surgical long-term effect. The primary efficacy endpoint is the
recurrence rate of pneumothorax within 24 months after surgery. The calculated
sample size is 360 patients (n = 180 per treatment arm) to prove superiority
of one of the two treatments. So far, 22 surgical sites have submitted their
declaration of commitment, giving the estimated number of participating
patients. Discussion A prospective randomized clinical trial has been started
to compare two established surgical therapies to evaluate the long-term
results regarding recurrence rates. Furthermore, cost of treatment, and
influence on the perioperative morbidity and mortality as well as on quality
of life are analyzed. If the study reveals equivalence for both surgical
techniques, unnecessary pulmonary resections could be avoided
A Barrier to Defend - Models of Pulmonary Barrier to Study Acute Inflammatory Diseases
Pulmonary diseases represent four out of ten most common causes for worldwide mortality. Thus, pulmonary infections with subsequent inflammatory responses represent a major public health concern. The pulmonary barrier is a vulnerable entry site for several stress factors, including pathogens such as viruses, and bacteria, but also environmental factors e.g. toxins, air pollutants, as well as allergens. These pathogens or pathogen-associated molecular pattern and inflammatory agents e.g. damage-associated molecular pattern cause significant disturbances in the pulmonary barrier. The physiological and biological functions, as well as the architecture and homeostatic maintenance of the pulmonary barrier are highly complex. The airway epithelium, denoting the first pulmonary barrier, encompasses cells releasing a plethora of chemokines and cytokines, and is further covered with a mucus layer containing antimicrobial peptides, which are responsible for the pathogen clearance. Submucosal antigen-presenting cells and neutrophilic granulocytes are also involved in the defense mechanisms and counterregulation of pulmonary infections, and thus may directly affect the pulmonary barrier function. The detailed understanding of the pulmonary barrier including its architecture and functions is crucial for the diagnosis, prognosis, and therapeutic treatment strategies of pulmonary diseases. Thus, considering multiple side effects and limited efficacy of current therapeutic treatment strategies in patients with inflammatory diseases make experimental in vitro and in vivo models necessary to improving clinical therapy options. This review describes existing models for studyying the pulmonary barrier function under acute inflammatory conditions, which are meant to improve the translational approaches for outcome predictions, patient monitoring, and treatment decision-making. Copyright © 2022 Herminghaus, Kozlov, Szabó, Hantos, Gylstorff, Kuebart, Aghapour, Wissuwa, Walles, Walles, Coldewey and Relja
A Barrier to Defend - Models of Pulmonary Barrier to Study Acute Inflammatory Diseases
Pulmonary diseases represent four out of ten most common causes for worldwide mortality. Thus, pulmonary infections with subsequent inflammatory responses represent a major public health concern. The pulmonary barrier is a vulnerable entry site for several stress factors, including pathogens such as viruses, and bacteria, but also environmental factors e.g. toxins, air pollutants, as well as allergens. These pathogens or pathogen-associated molecular pattern and inflammatory agents e.g. damage-associated molecular pattern cause significant disturbances in the pulmonary barrier. The physiological and biological functions, as well as the architecture and homeostatic maintenance of the pulmonary barrier are highly complex. The airway epithelium, denoting the first pulmonary barrier, encompasses cells releasing a plethora of chemokines and cytokines, and is further covered with a mucus layer containing antimicrobial peptides, which are responsible for the pathogen clearance. Submucosal antigen-presenting cells and neutrophilic granulocytes are also involved in the defense mechanisms and counterregulation of pulmonary infections, and thus may directly affect the pulmonary barrier function. The detailed understanding of the pulmonary barrier including its architecture and functions is crucial for the diagnosis, prognosis, and therapeutic treatment strategies of pulmonary diseases. Thus, considering multiple side effects and limited efficacy of current therapeutic treatment strategies in patients with inflammatory diseases make experimental in vitro and in vivo models necessary to improving clinical therapy options. This review describes existing models for studyying the pulmonary barrier function under acute inflammatory conditions, which are meant to improve the translational approaches for outcome predictions, patient monitoring, and treatment decision-making
How to prepare for academic leadership: scientific training curriculum
Thoracic surgery has evolved into an independent discipline out of general surgery practice over the past decades. The development of the field of thoracic surgery was generated from surgeons being motivated to move this field forward by constant analysis and critical appraisal and review of current practice, as well as identification of new research approaches as the pool and generator of innovation. For this purpose, scientific skills are needed that are currently not covered during the surgical training. In the present overview, we will try to summarize important factors for an academic career, although none of these recommendations are validated and also not realistic to be uniquely applied to every geographical setting. Several key factors will be described being necessary for pursuing basic science, translational, and clinical research as a surgeon scientist introducing "from bench to bedside" research ideas into clinic and "from bedside to bench" bringing important clinical problems back to the lab
Optimization of Primary Human Bronchial Epithelial 3D Cell Culture with Donor-Matched Fibroblasts and Comparison of Two Different Culture Media
In vitro airway models are increasingly important for pathomechanistic analyses of respiratory diseases. Existing models are limited in their validity by their incomplete cellular complexity. We therefore aimed to generate a more complex and meaningful three-dimensional (3D) airway model. Primary human bronchial epithelial cells (hbEC) were propagated in airway epithelial cell growth (AECG) or PneumaCult ExPlus medium. Generating 3D models, hbEC were airlifted and cultured on a collagen matrix with donor-matched bronchial fibroblasts for 21 days comparing two media (AECG or PneumaCult ALI (PC ALI)). 3D models were characterized by histology and immunofluorescence staining. The epithelial barrier function was quantified by transepithelial electrical resistance (TEER) measurements. The presence and function of ciliated epithelium were determined by Western blot and microscopy with high-speed camera. In 2D cultures, an increased number of cytokeratin 14-positive hbEC was present with AECG medium. In 3D models, AECG medium accounted for high proliferation, resulting in hypertrophic epithelium and fluctuating TEER values. Models cultured with PC ALI medium developed a functional ciliated epithelium with a stable epithelial barrier. Here, we established a 3D model with high in vivo–in vitro correlation, which has the potential to close the translational gap for investigations of the human respiratory epithelium in pharmacological, infectiological, and inflammatory research
- …